1. Home
  2. PGEN vs MSB Comparison

PGEN vs MSB Comparison

Compare PGEN & MSB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PGEN
  • MSB
  • Stock Information
  • Founded
  • PGEN 1998
  • MSB 1961
  • Country
  • PGEN United States
  • MSB United States
  • Employees
  • PGEN N/A
  • MSB N/A
  • Industry
  • PGEN Biotechnology: Pharmaceutical Preparations
  • MSB Metal Mining
  • Sector
  • PGEN Health Care
  • MSB Basic Materials
  • Exchange
  • PGEN Nasdaq
  • MSB Nasdaq
  • Market Cap
  • PGEN 404.4M
  • MSB 332.3M
  • IPO Year
  • PGEN N/A
  • MSB N/A
  • Fundamental
  • Price
  • PGEN $1.32
  • MSB $25.10
  • Analyst Decision
  • PGEN Strong Buy
  • MSB
  • Analyst Count
  • PGEN 4
  • MSB 0
  • Target Price
  • PGEN $7.33
  • MSB N/A
  • AVG Volume (30 Days)
  • PGEN 1.8M
  • MSB 39.1K
  • Earning Date
  • PGEN 05-14-2025
  • MSB 01-01-0001
  • Dividend Yield
  • PGEN N/A
  • MSB 28.68%
  • EPS Growth
  • PGEN N/A
  • MSB 391.35
  • EPS
  • PGEN N/A
  • MSB 7.11
  • Revenue
  • PGEN $4,201,000.00
  • MSB $27,410,622.00
  • Revenue This Year
  • PGEN $189.12
  • MSB N/A
  • Revenue Next Year
  • PGEN $1,093.07
  • MSB N/A
  • P/E Ratio
  • PGEN N/A
  • MSB $3.53
  • Revenue Growth
  • PGEN N/A
  • MSB 19.90
  • 52 Week Low
  • PGEN $0.65
  • MSB $15.93
  • 52 Week High
  • PGEN $2.17
  • MSB $37.00
  • Technical
  • Relative Strength Index (RSI)
  • PGEN 44.03
  • MSB 40.46
  • Support Level
  • PGEN $1.35
  • MSB $24.81
  • Resistance Level
  • PGEN $1.53
  • MSB $25.84
  • Average True Range (ATR)
  • PGEN 0.12
  • MSB 0.90
  • MACD
  • PGEN 0.00
  • MSB -0.06
  • Stochastic Oscillator
  • PGEN 22.22
  • MSB 34.45

About PGEN Precigen Inc.

Precigen Inc is a biotechnology company that develops synthetic biology solutions. The company designs build and regulate gene programs. Its technologies are broadly applicable across a wide range of diverse end markets. Intrexon's business model is to commercialize its technologies through exclusive channel collaborations with collaborators that have specific industry expertise, development resources, and sales and marketing capabilities, in order to bring new and improved products and processes to market. Its reportable segments are Biopharmaceuticals and Exemplar. The company's collaborators provide compensation through technology access fees, royalties, milestones, and reimbursement of certain costs.

About MSB Mesabi Trust

Mesabi Trust operates as a royalty trust in the United States. The company is involved in the conservation and protection of its assets. The company's principally wholly-owned segment is the iron ore mining segment, which generates income from the Peter Mitchell Mine, an iron mine located near Babbitt, Minnesota, at the eastern end of the Mesabi Iron Range.

Share on Social Networks: